HK Stock MarketDetailed Quotes
03320 CHINARES PHARMA
- 5.410
- -0.030-0.55%
Market Closed Dec 13 16:08 CST
33.99BMarket Cap8.21P/E (TTM)
5.470High5.370Low6.53MVolume5.470Open5.440Pre Close35.34MTurnover0.10%Turnover Ratio7.99P/E (Static)6.28BShares7.11052wk High0.64P/B33.99BFloat Cap4.19052wk Low0.26Dividend TTM6.28BShs Float12.230Historical High0.170Dividend LFY1.84%Amplitude2.610Historical Low5.412Avg Price500Lot Size4.82%Div YieldTTM3.14%Div Yield LFY
CHINARES PHARMA Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 12.14%7.05B | 18.17%9.88B | -4.53%6.28B | -0.56%8.36B | 27.39%6.58B | 18.84%8.41B | 15.07%5.17B | 6.57%7.08B | -22.70%4.49B | -28.16%6.64B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -59.52%-372.15M | 18.51%-587.69M | 45.84%-233.3M | 1.12%-721.18M | -59.41%-430.74M | -7.93%-729.33M | ---270.2M | -6.22%-675.77M | ---- | 11.16%-636.18M |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---7.61M | 49.75%-2.22M | ---- | 45.17%-4.41M | 64.75%-1.02M | -263.13%-8.05M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 60.58%-4M | ---- |
| Attributable subsidiary (profit) loss | 6.25%-198.77M | -25.51%-417.11M | -14.04%-212.01M | -5.98%-332.34M | -30.26%-185.91M | -51.60%-313.6M | -89.37%-142.73M | -47.31%-206.85M | -11.51%-75.37M | -2.37%-140.42M |
| Impairment and provisions: | 23.22%735.08M | 26.12%1.35B | 4.50%596.55M | -21.70%1.07B | 24.34%570.85M | -25.82%1.36B | -13.21%459.1M | 40.97%1.84B | 99.46%528.95M | 598.95%1.3B |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | -96.73%1.35M | 1,561.75%139.29M | 3,556.68%41.36M | -77.54%8.38M | -85.91%1.13M | 65.53%37.32M |
| -Impairmen of inventory (reversal) | 3.14%30.58M | 129.39%210.28M | -21.48%29.64M | -81.62%91.67M | -57.75%37.75M | 63.96%498.87M | 93.96%89.36M | 353.47%304.27M | 847.57%46.07M | 51.26%67.1M |
| -Impairment of trade receivables (reversal) | 12.82%113.47M | ---- | -79.42%100.58M | ---- | 55.66%488.64M | -28.64%556.94M | -29.38%313.91M | 74.62%780.42M | 65.69%444.54M | 389.92%446.93M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | -78.96%123.75M | ---- | -18.61%588.14M | ---- | 3,493.35%722.59M |
| -Other impairments and provisions | 26.74%591.03M | 16.41%1.14B | 981.83%466.32M | 2,100.58%975.76M | 197.93%43.11M | -71.66%44.34M | -61.12%14.47M | 427.72%156.47M | 332.64%37.21M | 258.54%29.65M |
| Revaluation surplus: | 77.30%-21.83M | -15.38%496.65M | -145.99%-96.18M | 55.28%586.92M | 438.55%209.12M | 473.10%377.96M | -429.65%-61.77M | -204.67%-101.3M | 79.78%-11.66M | 80.39%-33.25M |
| -Fair value of investment properties (increase) | 102.59%1.25M | -80.37%24.65M | -178.16%-48.3M | 763.75%125.58M | --61.8M | -315.00%-18.92M | ---- | -131.59%-4.56M | ---- | 117.74%14.43M |
| -Other fair value changes | 51.79%-23.08M | 2.31%472M | -132.50%-47.88M | 16.24%461.33M | 338.51%147.32M | 510.23%396.88M | -429.65%-61.77M | -102.89%-96.75M | 79.78%-11.66M | 45.92%-47.68M |
| Asset sale loss (gain): | -2,647.37%-20.36M | 80.93%-63.85M | 99.82%-741K | -3,383.21%-334.84M | -4,001.53%-405.93M | -242.94%-9.61M | -349.55%-9.9M | 100.62%6.73M | 100.37%3.97M | -9,288.04%-1.08B |
| -Loss (gain) from sale of subsidiary company | -1,399.47%-22.05M | 88.47%-38.69M | 100.43%1.7M | -10,474.67%-335.64M | -5,143.31%-399.23M | 91.77%-3.17M | ---7.61M | 96.47%-38.56M | ---- | -198,317.27%-1.09B |
| -Loss (gain) on sale of property, machinery and equipment | 168.39%1.69M | 1,426.41%12.2M | 63.26%-2.48M | 112.41%799K | -195.31%-6.74M | -114.22%-6.44M | -157.56%-2.28M | 605.20%45.28M | 711.04%3.97M | -8.90%6.42M |
| -Loss (gain) from selling other assets | ---- | ---37.36M | -2.50%39K | ---- | --40K | ---- | ---- | ---- | ---- | 108.80%1.59M |
| Depreciation and amortization: | 5.90%1.63B | 23.68%3.16B | -4.09%1.54B | -9.34%2.56B | 17.42%1.6B | 15.46%2.82B | 13.43%1.37B | 3.35%2.44B | 7.01%1.2B | 46.30%2.36B |
| -Amortization of intangible assets | 4.65%296.02M | 41.80%590.54M | 12.61%282.86M | 18.11%416.45M | 56.30%251.19M | 45.21%352.6M | 23.06%160.71M | -2.09%242.81M | 11.22%130.59M | 20.33%248M |
| -Other depreciation and amortization | ---- | ---- | --7.82M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial expense | -17.60%1.18B | -2.74%2.39B | 4.87%1.43B | -10.61%2.45B | -7.39%1.36B | -12.96%2.74B | -5.32%1.47B | -15.06%3.15B | -9.43%1.55B | 16.13%3.71B |
| Special items | -122.98%-5.47M | 688.28%49.99M | 127.92%23.81M | 105.99%6.34M | -3.39%-85.26M | -65.46%-105.96M | 77.98%-82.47M | 37.03%-64.04M | -2.97%-374.52M | -12.99%-101.7M |
| Operating profit before the change of operating capital | 6.86%9.97B | 19.13%16.26B | 1.27%9.33B | -6.25%13.65B | 16.68%9.21B | 8.10%14.56B | 7.94%7.9B | 12.04%13.46B | -0.46%7.31B | -8.37%12.02B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -30.98%-5.15B | -19.47%-2.67B | -403.45%-3.93B | 34.52%-2.23B | 68.31%-781.2M | -323.40%-3.41B | -7.47%-2.46B | -49.88%-805.55M | -156.42%-2.29B | -1,922.93%-537.47M |
| Accounts receivable (increase)decrease | 12.68%-14.93B | 6.83%-6.33B | -9.82%-17.09B | -30.79%-6.8B | -31.28%-15.56B | -1.50%-5.2B | -234.11%-11.86B | 32.51%-5.12B | 71.41%-3.55B | -109.14%-7.59B |
| Accounts payable increase (decrease) | 15.24%9.95B | 33.41%10.5B | 53.24%8.63B | -1.73%7.87B | -18.28%5.63B | 407.99%8.01B | 621.49%6.89B | -74.59%1.58B | -134.56%-1.32B | 2,537.38%6.21B |
| Special items for working capital changes | -6.21%620.54M | -82.20%98.96M | 314.23%661.62M | -37.97%555.8M | 46.02%-308.84M | 52.79%895.95M | -175.90%-572.11M | 722.55%586.4M | 405.58%753.73M | -128.92%-94.19M |
| Cash from business operations | 119.14%460.17M | 36.90%17.86B | -32.82%-2.4B | -12.20%13.04B | -1,633.65%-1.81B | 53.11%14.86B | -111.55%-104.4M | -3.03%9.7B | 138.00%904.05M | -0.72%10.01B |
| Other taxs | -8.38%-1.48B | -3.80%-2.31B | 4.74%-1.37B | -10.38%-2.22B | -15.28%-1.43B | -34.57%-2.01B | -39.26%-1.24B | 19.77%-1.5B | 19.81%-892.97M | -1.81%-1.86B |
| Net cash from operations | 72.95%-1.02B | 43.70%15.55B | -16.22%-3.77B | -15.74%10.82B | -140.62%-3.24B | 56.50%12.84B | -12,257.92%-1.35B | 0.80%8.21B | 100.32%11.09M | -1.29%8.14B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 153.15%372.15M | -18.51%587.69M | -26.59%147.01M | -28.98%721.18M | 69.48%200.27M | 14.55%1.02B | -57.76%118.17M | 27.01%886.46M | -16.94%279.75M | -2.54%697.95M |
| Dividend received - investment | -30.96%58.99M | 170.79%87.85M | 158.50%85.44M | 77.91%32.44M | 803.55%33.05M | -49.40%18.24M | -89.79%3.66M | 20.30%36.04M | 245.00%35.84M | -47.16%29.96M |
| Loan receivable (increase) decrease | --302.97M | -36.76%937M | ---- | 325.84%1.48B | 113.92%100.09M | -231.15%-656.04M | -161.05%-718.81M | 139.81%500.23M | 833.74%1.18B | 109.96%208.6M |
| Decrease in deposits (increase) | 122.06%291.68M | -73.69%306.98M | -506.54%-1.32B | 211.77%1.17B | 79.14%-217.97M | 6.57%-1.04B | -87.66%-1.05B | -6.12%-1.12B | -1,180.23%-556.95M | -353.12%-1.05B |
| Sale of fixed assets | 156.72%60.03M | 142.25%176.95M | 127.99%23.39M | -49.17%73.05M | -66.22%10.26M | 51.38%143.71M | -43.50%30.37M | 3.75%94.94M | 74.63%53.74M | 226.89%91.51M |
| Purchase of fixed assets | 6.76%-1.05B | -10.69%-2.52B | 4.90%-1.13B | -5.20%-2.28B | -44.08%-1.19B | -29.80%-2.17B | -41.55%-824.17M | -4.54%-1.67B | 25.99%-582.27M | -5.50%-1.6B |
| Selling intangible assets | 2,908.70%1.38M | -95.37%2.03M | --46K | --43.92M | ---- | ---- | ---- | ---- | ---- | 89.80%41.22M |
| Purchase of intangible assets | -50.54%-184.54M | -32.32%-609.48M | 58.57%-122.59M | 26.52%-460.61M | -876.76%-295.92M | -14.12%-626.86M | 82.05%-30.3M | -46.78%-549.3M | -397.18%-168.78M | 16.21%-374.25M |
| Sale of subsidiaries | 629.85%197.66M | -85.36%63.85M | -95.12%27.08M | 86.06%436.21M | 3,646.53%554.67M | -77.39%234.45M | -98.30%14.81M | 426.34%1.04B | 201.92%872.79M | 133,229.73%197.03M |
| Acquisition of subsidiaries | -136.60%-349.08M | 170.45%646.53M | 3,048.09%953.68M | 47.16%-917.77M | -98.02%-32.35M | -49.37%-1.74B | 98.57%-16.34M | -262.72%-1.16B | -201.68%-1.15B | 132.61%714.58M |
| Recovery of cash from investments | 51.70%14.41B | -19.68%22.36B | -37.79%9.5B | 10.84%27.83B | 29.34%15.27B | -29.48%25.11B | -47.41%11.8B | -8.74%35.61B | -0.47%22.44B | 129.71%39.02B |
| Cash on investment | -122.27%-17.64B | 16.89%-24.15B | 50.72%-7.94B | 2.23%-29.06B | -26.34%-16.11B | 17.46%-29.73B | 51.47%-12.75B | 2.58%-36.01B | -19.15%-26.27B | -74.26%-36.97B |
| Other items in the investment business | 61.53%76.58M | -52.45%53.04M | -5.89%47.41M | -54.05%111.55M | 139.51%50.37M | 164.82%242.77M | 162.38%21.03M | --91.68M | -10.99%8.02M | ---- |
| Net cash from investment operations | -1,383.12%-3.46B | -152.34%-2.07B | 116.57%269.69M | 91.09%-819.24M | 52.04%-1.63B | -307.64%-9.19B | 11.98%-3.39B | -323.50%-2.25B | -380.23%-3.86B | 110.29%1.01B |
| Net cash before financing | -28.01%-4.48B | 34.80%13.48B | 28.15%-3.5B | 173.90%10B | -2.73%-4.87B | -38.64%3.65B | -23.33%-4.74B | -34.95%5.95B | -81.62%-3.84B | 688.77%9.15B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -13.44%43.67B | -11.88%77.97B | -24.96%50.45B | -0.26%88.48B | 64.66%67.23B | 54.11%88.7B | -0.51%40.83B | 3.11%57.56B | 18.06%41.04B | -30.20%55.82B |
| Refund | 4.71%-38.76B | 11.41%-81.8B | 31.57%-40.67B | -15.53%-92.33B | -88.83%-59.44B | -39.03%-79.92B | 16.47%-31.48B | 8.85%-57.48B | -26.87%-37.69B | 7.17%-63.06B |
| Issuance of bonds | 50.00%3B | 0.00%2B | -16.54%2B | -33.24%2B | -20.01%2.4B | -33.43%3B | -31.88%3B | 0.77%4.5B | 52.68%4.4B | -44.02%4.47B |
| Interest paid - financing | 9.78%-1.18B | -36.52%-2.64B | 4.11%-1.3B | 27.08%-1.94B | -56.66%-1.36B | 6.87%-2.66B | 13.08%-867.08M | 21.11%-2.85B | 43.38%-997.6M | -27.50%-3.61B |
| Dividends paid - financing | -42.15%-1.91B | -19.19%-3.23B | -92.54%-1.35B | -43.44%-2.71B | 22.67%-698.84M | -26.67%-1.89B | -134.95%-903.69M | 25.58%-1.49B | 62.27%-384.63M | 50.10%-2B |
| Absorb investment income | 622.49%2.14B | 378.33%3.63B | 12.18%296.68M | 118.05%758.79M | 608.03%264.48M | 808.49%347.99M | 304.97%37.35M | -77.62%38.3M | -91.70%9.22M | -13.57%171.17M |
| Issuance expenses and redemption of securities expenses | ---2.58B | 88.34%-516.84M | ---- | 13.45%-4.43B | ---1.51B | 25.88%-5.12B | ---- | -0.69%-6.91B | 34.65%-2.37B | -28.59%-6.86B |
| Other items of the financing business | -260.58%-1.98B | -28.13%1.15B | 531.56%1.23B | 30.08%1.59B | 21.48%-285.94M | 35.37%1.23B | -149.14%-364.16M | -66.73%905.65M | 155.97%741.06M | 180.81%2.72B |
| Net cash from financing operations | -79.52%2.12B | 55.45%-4.07B | 56.70%10.33B | -403.66%-9.13B | -35.67%6.59B | 146.85%3.01B | 116.12%10.25B | 50.69%-6.41B | 1,449.38%4.74B | -378.74%-13.01B |
| Effect of rate | -38.60%5.74M | -69.73%9.66M | 101.16%9.35M | 108.80%31.92M | -405.47%-803.43M | 57.52%-362.69M | -5.96%263.01M | -274.36%-853.81M | 6,035.53%279.68M | 65.01%-228.07M |
| Net Cash | -134.61%-2.36B | 975.24%9.42B | 296.76%6.83B | -86.84%875.83M | -68.73%1.72B | 1,538.32%6.66B | 513.73%5.51B | 88.01%-462.84M | 149.55%897.23M | -223.98%-3.86B |
| Begining period cash | 61.92%24.65B | 6.34%15.22B | -13.14%15.22B | 27.46%14.32B | 56.04%17.53B | -10.49%11.23B | -10.49%11.23B | -24.57%12.55B | -24.56%12.55B | 17.37%16.64B |
| Cash at the end | 1.03%22.29B | 61.92%24.65B | 19.63%22.06B | -13.14%15.22B | 8.49%18.44B | 56.04%17.53B | 23.87%17B | -10.49%11.23B | -7.37%13.73B | -24.57%12.55B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
